Is RxSight, Inc. (RXST) Halal?

NASDAQ Healthcare United States $258M
✗ NOT HALAL
Confidence: 90/100
RxSight, Inc. (RXST) is Not Halal under AAOIFI Standard 21. While the debt ratio of 3.5% is acceptable, the cash and interest-bearing securities ratio of 71.9% exceeds the 30% threshold. RxSight, Inc. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 3.5%
/ 30%
71.9%
/ 30%
7.4%
/ 30%
6.94%
/ 5%
✗ NOT HALAL
DJIM 3.5%
/ 33%
71.9%
/ 33%
7.4%
/ 33%
6.94%
/ 5%
✗ NOT HALAL
MSCI 3.5%
/ 33%
73.2%
/ 33%
7.5%
/ 33%
6.94%
/ 5%
✗ NOT HALAL
S&P 3.5%
/ 33%
71.9%
/ 33%
7.4%
/ 33%
6.94%
/ 5%
✗ NOT HALAL
FTSE 3.5%
/ 33%
73.2%
/ 33%
7.5%
/ 50%
6.94%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-0.95
P/B Ratio
0.9
EV/EBITDA
-0.9
EV: $41M
Revenue
$134M
Growth: -18.9%
Beta
1.2
Average volatility
Current Ratio
10.9

Profitability

Gross Margin 76.6%
Operating Margin -34.8%
Net Margin -29.0%
Return on Equity (ROE) -14.0%
Return on Assets (ROA) -9.6%

Cash Flow & Balance Sheet

Operating Cash Flow-$16M
Free Cash Flow-$19M
Total Debt$11M
Debt-to-Equity4.0
Current Ratio10.9
Total Assets$312M

Price & Trading

Last Close$6.49
50-Day MA$8.11
200-Day MA$9.38
Avg Volume928K
Beta1.2
52-Week Range
$6.02
$26.38

About RxSight, Inc. (RXST)

CEO
Dr. Ronald M. Kurtz M.D.
Employees
461
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$258M
Currency
USD

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is RxSight, Inc. (RXST) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), RxSight, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is RxSight, Inc.'s debt ratio?

RxSight, Inc.'s debt ratio is 3.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 3.5%.

What are RxSight, Inc.'s key financial metrics?

RxSight, Inc. has a market capitalization of $258M, and revenue of $134M. The company maintains a gross margin of 76.6% and a net margin of -29.0%. Return on equity stands at -14.0%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.